164 related articles for article (PubMed ID: 24458249)
21. Hormonal regulation of regucalcin mRNA expression in osteoblastic MC3T3-E1 cells.
Yamaguchi M; Otomo Y; Uchiyama S; Nakagawa T
Int J Mol Med; 2008 Jun; 21(6):771-5. PubMed ID: 18506371
[TBL] [Abstract][Full Text] [Related]
22. Involvement of regucalcin in lipid metabolism and diabetes.
Yamaguchi M; Murata T
Metabolism; 2013 Aug; 62(8):1045-51. PubMed ID: 23453039
[TBL] [Abstract][Full Text] [Related]
23. The bone anabolic carotenoid p-hydroxycinnamic acid promotes osteoblast mineralization and suppresses osteoclast differentiation by antagonizing NF-κB activation.
Yamaguchi M; Weitzmann MN
Int J Mol Med; 2012 Sep; 30(3):708-12. PubMed ID: 22751682
[TBL] [Abstract][Full Text] [Related]
24. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
25. Alternatively spliced variants of the regucalcin gene in various human normal and tumor tissues.
Murata T; Yamaguchi M
Int J Mol Med; 2014 Oct; 34(4):1141-6. PubMed ID: 25050833
[TBL] [Abstract][Full Text] [Related]
26. IL-1 plays an important role in the bone metabolism under physiological conditions.
Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y
Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512
[TBL] [Abstract][Full Text] [Related]
27. Overexpression of regucalcin suppresses cell response for tumor necrosis factor-alpha or transforming growth factor-beta1 in cloned normal rat kidney proximal tubular epithelial NRK52E cells.
Nakagawa T; Yamaguchi M
J Cell Biochem; 2007 Apr; 100(5):1178-90. PubMed ID: 17063480
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of regucalcin suppresses cell proliferation in cloned rat hepatoma H4-II-E cells: involvement of intracellular signaling factors and cell cycle-related genes.
Yamaguchi M; Daimon Y
J Cell Biochem; 2005 Aug; 95(6):1169-77. PubMed ID: 15962315
[TBL] [Abstract][Full Text] [Related]
29. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
[TBL] [Abstract][Full Text] [Related]
30. Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro.
Yamaguchi M; Osuka S; Weitzmann MN; El-Rayes BF; Shoji M; Murata T
Int J Oncol; 2016 May; 48(5):1955-64. PubMed ID: 26935290
[TBL] [Abstract][Full Text] [Related]
31. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
[TBL] [Abstract][Full Text] [Related]
32. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
33. Nuclear localization of regucalcin is enhanced in culture with protein kinase C activation in cloned normal rat kidney proximal tubular epithelial NRK52E cells.
Nakagawa T; Yamaguchi M
Int J Mol Med; 2008 May; 21(5):605-10. PubMed ID: 18425353
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of regucalcin blocks the migration, invasion, and bone metastatic activity of human prostate cancer cells: Crosstalk between cancer cells and bone cells.
Yamaguchi M; Murata T; Ramos JW
Prostate; 2022 Jun; 82(10):1025-1039. PubMed ID: 35365850
[TBL] [Abstract][Full Text] [Related]
35. The role of regucalcin in nuclear regulation of regenerating liver.
Yamaguchi M
Biochem Biophys Res Commun; 2000 Sep; 276(1):1-6. PubMed ID: 11006072
[TBL] [Abstract][Full Text] [Related]
36. Role of calcium-binding protein regucalcin in regenerating rat liver.
Yamaguchi M
J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S106-12. PubMed ID: 9792043
[TBL] [Abstract][Full Text] [Related]
37. The transcriptional regulation of regucalcin gene expression.
Yamaguchi M
Mol Cell Biochem; 2011 Jan; 346(1-2):147-71. PubMed ID: 20936536
[TBL] [Abstract][Full Text] [Related]
38. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
39. Prolonged survival of patients with colorectal cancer is associated with a higher regucalcin gene expression: Overexpression of regucalcin suppresses the growth of human colorectal carcinoma cells in vitro.
Yamaguchi M; Osuka S; Murata T
Int J Oncol; 2018 Sep; 53(3):1313-1322. PubMed ID: 29956741
[TBL] [Abstract][Full Text] [Related]
40. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
